iifl-logo

Starsource Multitrade Ltd Board Meeting

Add as a Preferred Source on Google
81
(-0.61%)
Aug 28, 2026|10:45:00 AM

Chemo Pharma Lab CORPORATE ACTIONS

28/08/2025calendar-icon
28/08/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 Aug 202611 Aug 2026
Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve un-audited financial results for the quarter ended on June 30 2026 along with Limited Review Report thereon.
Board Meeting29 May 202625 May 2026
Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results for the Fourth Quarter and Financial Year ended March 31 2026 along with the Auditors Report thereon. Outcome of Board Meeting held on May 29, 2026 - Audited Standalone Financial Results of the Company for the fourth quarter and Year ended March 31, 2026. Audited Financial Result for the fourth quarter and year ended on March 31, 2026. (As Per BSE Announcement Dated on:29.05.2026)
Board Meeting12 Feb 20269 Feb 2026
Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Un-Audited Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report thereon. Unaudited Financial Results for the quarter and nine months ended December 31, 2025. (As per BSE announcement dated on : 12.02.2026) Revised Outcome of Board Meeting held on February 12, 2026. (Correction in typo of outcome Time). Correct time is 12:45 PM. (As per BSE Announcement dated on: 16.02.2026)
Board Meeting13 Nov 202510 Nov 2025
Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve unaudited financial results for the Quarter And Half Year ended 30th September 2025 Unaudited Financial Results for the quarter and half year ended September 30, 2025 Results for the Quarter and Half Year ended September 30, 2025 (As Per BSE Announcement Dated on:13.11.2025)
Board Meeting12 Sep 202512 Sep 2025
Appointment of Mr. Aditya Agarwal as new Company Secretary & Compliance Officer of the Company and resignation of Ms. Bhawna Rajput from the post of company secretary & Compliance Officer of the Company

Chemo Pharma Lab: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.